These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2921130)

  • 21. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Nasopharyngeal carcinoma in childhood].
    Huang TB
    Zhonghua Zhong Liu Za Zhi; 1990 Mar; 12(2):123-6. PubMed ID: 2401174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective study of p53 expression and its correlation with clinical response of radiotherapy in nasopharyngeal carcinoma.
    Ho KY; Kuo WR; Chai CY; Tsai SM; Sheu SH; Wu SC; Juan KH
    Laryngoscope; 2001 Jan; 111(1):131-6. PubMed ID: 11192881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Split-course radiotherapy of squamous cell cancer of the lung].
    Zhakov IG; Il'in VI
    Vopr Onkol; 1979; 25(10):41-4. PubMed ID: 506180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reirradiation for locally recurrent nasopharyngeal carcinoma: treatment results and prognostic factors.
    Oksüz DC; Meral G; Uzel O; Cağatay P; Turkan S
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):388-94. PubMed ID: 15380570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent nasopharyngeal carcinoma: current management approaches.
    Smee RI; Meagher NS; Broadley K; Ho T; Williams JR; Bridger GP
    Am J Clin Oncol; 2010 Oct; 33(5):469-73. PubMed ID: 19935385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 10-year survival rate for patient with nasopharyngeal carcinoma after radiation therapy. Clinical analysis of 367 cases.
    Chen CQ; Liu TF; Zhao S
    Chin Med J (Engl); 1989 Apr; 102(4):239-42. PubMed ID: 2507236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma: an evaluation of response and toxicity.
    Lu JJ; Shakespeare TP; Thiagarajan A; Zhang X; Liang L; Tan S
    Laryngoscope; 2005 May; 115(5):806-10. PubMed ID: 15867644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Primary radiotherapy of nasopharyngeal carcinoma].
    Rübe C; Grevers G; Grimminger H; Wendt T; Rohloff R
    Laryngorhinootologie; 1995 Feb; 74(2):103-7. PubMed ID: 7710601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation therapy of nasopharyngeal carcinoma: prognostic factors based on a 10-year follow-up of 1302 patients.
    Zhang EP; Lian PG; Cai KL; Chen YF; Cai MD; Zheng XF; Guang XX
    Int J Radiat Oncol Biol Phys; 1989 Feb; 16(2):301-5. PubMed ID: 2921129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of Selaginella combined with radiotherapy on nasopharyngeal carcinoma].
    Zheng JX; Zhou TC; Xu K; Li LN
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):247-8. PubMed ID: 16503545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognostic factors of nasopharyngeal carcinoma treated by radiotherapy].
    Shigematsu N; Ito H; Oki Y; Kawada T; Suzuki T; Takeda A; Uematsu M; Kubo A; Fujii M; Kanzaki H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Dec; 56(14):1050-5. PubMed ID: 9014467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nasopharyngeal cancer in the Middle East: experience of the American University of Beirut Medical Center.
    Geara FB; Nasr E; Tucker SL; Brihi E; Zaytoun G; Hadi U; Salem Z; El Saghir N; Issa P; Shamseddine A
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1408-15. PubMed ID: 15817344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prospective study on long-term efficacy of external plus intracavitary radiotherapy on stage I-II nasopharyngeal carcinoma].
    Cao XP; Lu TX; Ye WJ; Cui NJ
    Ai Zheng; 2007 Feb; 26(2):204-7. PubMed ID: 17298754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Radiotherapy on neck for nasopharyngeal carcinoma patients with negative cervical lymph node].
    Li Y; Cao KJ; Chen QY; Xie GF; Huang PY
    Ai Zheng; 2005 May; 24(5):627-30. PubMed ID: 15890111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy.
    Kong L; Lu JJ; Hu C; Guo X; Wu Y; Zhang Y
    Cancer; 2006 Sep; 107(6):1287-93. PubMed ID: 16909425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Radiotherapy of inoperable, loco-regional epidermoid carcinoma of the lung. 5-year experience].
    Morera E; Peretti G; Nuzzo A; Basilico N; D'Alessandro M; Basilico L
    Radiol Med; 1986 Sep; 72(9):664-6. PubMed ID: 3763971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nasopharyngeal carcinoma with cranial nerve palsy: the importance of MRI for radiotherapy.
    Chang JT; Lin CY; Chen TM; Kang CJ; Ng SH; Chen IH; Wang HM; Cheng AJ; Liao CT
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1354-60. PubMed ID: 16297716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of University of Florida split-course technique for various head and neck squamous cell carcinomas.
    Million RR; Zimmermann RC
    Cancer; 1975 Jun; 35(6):1533-6. PubMed ID: 1148987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group.
    Chua DT; Sham JS; Choy D; Lorvidhaya V; Sumitsawan Y; Thongprasert S; Vootiprux V; Cheirsilpa A; Azhar T; Reksodiputro AH
    Cancer; 1998 Dec; 83(11):2270-83. PubMed ID: 9840526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.